chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccine was expired on 07-Apr-2022 and administered on 12-Apr-2022/  expired vaccine was administered after the 30-day Use By Date or after manufacturer date of expiration; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 07-Apr-2022 and administered on 12-Apr-2022/  expired vaccine was administered after the 30-day Use By Date or after manufacturer date of expiration) in an 80-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 070H21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 12-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 12-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 07-Apr-2022 and administered on 12-Apr-2022/  expired vaccine was administered after the 30-day Use By Date or after manufacturer date of expiration). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 07-Apr-2022 and administered on 12-Apr-2022/  expired vaccine was administered after the 30-day Use By Date or after manufacturer date of expiration) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications details were not reported by the reporter.  Reportedly, 173 doses or vials were initially stored in the refrigerator on an unknown date.  The vial did not undergo any temperature excursions.  Treatment details were not reported by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: Follow-up document contains no additional information.
Patient was inadvertantly given the Bexsero vaccine instead of the Gardasil. Patient was supposed to get the gardasil 9 instead.
Brain lesion left lower mid brain. Brain damage facial and hand nerve damage. Vision damage. Cognitive damage. Vertigo. Equilibrium and balance damage.
Pt felt lightheaded/dizzy - No LOC, no nausea - Pt remained in supine position, then sitting position over 20 min.
No adverse reaction at this time. Patient was given MMRV and Varicella Vaccine at same visit. Additional person responsible, MA.
Participant came to vaccine clinic to receive second dose of Moderna vaccine. Participant tolerated first dose well. First dose was administered in a medical recliner, given participant's history of fainting with vaccinations and blood draws. For second dose, participant was seated in medical recliner. Participant did eat and drink today. Vaccination administered. Within five minutes, participant fainted while in medical recliner. Patient came to immediately and said, "What happened?" Vital signs taken at 6:10pm BP 138/96. Pulse 78. O2 sat 100% on room air. Participant encouraged to go to Emergency Room for further evaluation. Participant declined. Participant and parents educated on if any symptoms arise to seek immediate medical attention. Advised to follow up with primary care provider regarding occurrence. Participant and parents verbalized understanding.
Breakthrough admission after 2 vaccines Moderna 3/11/21 Lot# 040A21A;,  Moderna 4/8/21 Lot# 016B21A
pt recvd vax & w/in a few hrs post vax pt exp a sz;ER or MD visit was required, pt was hospitalized;sxs subsided;addl info is being sought
COVID-19 TEST POSITIVE; This spontaneous report received from a consumer concerned a female of unspecified age, race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose was not reported, 1 total, administered on 26-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  The patient's husband reported that, the patient was tested positive for Covid-19 virus and was hospitalized (date and duration not specified). Laboratory data (dates unspecified) included: COVID-19 virus test (NR: not provided) Positive. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of covid-19 test positive was not reported. This report was serious (Hospitalization Caused / Prolonged). This case, from the same reporter is linked to 20210807871 and 20210808196.; Sender's Comments: V0: 20210807550-Covid-19 vaccine ad26.cov2.s -Covid-19 test positive . This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Rash to left arm, red with white ring around the red area of inflammation-urticarial, warm to the touch. 9x11cm, tenderness, blisters to corners to mouth (representative of herpes simplex 1 outbreak). Tx: Prednisone-taper dose.
Pt. developed pain, swelling, redness, itch in (L) deltoid 1 day after immunization TDAP.
This spontaneous report as received from a female consumer of unknown age refers to herself. The patient had allergy to penicillin. The patient had no pertinent medical history. The patient was vaccinated with PNEUMOVAX23 injection, single dose in her left arm approximately "2 years ago in October" (on an unspecified date in October 2012)(route, lot # and expired date were not reported). Concomitant therapy was not reported. The patient stated that after receiving the injection in her left arm, her arm became red at the injection site and a rash spread "2 years ago October, specified date unspecified" (on an unspecified date in October 2012). the patient stated that there was swelling on he left arm "2 years ago October, specific date unspecified" (on an unspecified date in October 2013). The patient was not sure if the medication was PNEUMOVAX23 or not. The patient sought medical attention by talking with physician. The physician treated the adverse event with prednisone (manufacturer unknown). No lab diagnostics studies were performed. The outcome of adverse events was reported as recovered on an unspecified date. The reporter id not assessed the causality between adverse events and PNEUMOVAX23. Additional information has been requested.
3 days post vaccine mom reports warm pink area at inject site palm sized. C/O tenderness to axilla. No fever. F/U 4 days post vaccine-marked decreased in size and discomfort.
Eyelid swelling on one side, which was the side of vaccination, 8 hours after the dose, quite visible but only mildly bothersome
got a lypoma on my shoulder left  blade after my 1st shot; This is a spontaneous report from a contactable Consumer or other non-health care professional (Patient) reported in response to Non-health care professional letter sent to consumer via follow letter (in the cross-referenced case). A 49-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number EW0176), via intramuscularly, in upper Left arm on 24Aug2021 11:00 AM (at the age of 49-years-old) as DOSE 1, SINGLE for covid-19 immunization. Medical history included hypersensitivity from an unknown date and unknown if ongoing. Concomitant medications included fexofenadine hydrochloride, pseudoephedrine hydrochloride (ALLEGRA D) taken for hypersensitivity from Apr2021 and ongoing. On 2021, The patient experienced got a lypoma on patient shoulder left blade after her 1st shot. The outcome of the event was unknown. Follow-up attempts are completed. No further information is expected.
soreness in her upper right arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 28Feb2021 (Lot number: EL9266) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "soreness in her upper right arm".  Additional Information: The patient was concerned about having problems in a "spot" that was not where the shot was given. The patient was wondering if it was normal to have soreness or pain on the side other than where the shot was administered and if the cholesterol in the vaccine could raise patient's cholesterol levels.  No follow-up attempts are needed. No further information is expected.
Pinprick- like rash all over the torso, upper arms and thighs. Appearing about 4 hours after vaccine was administered, still present 24 hours later. Slightly itchy.
area where vaccine was given ( back of right upper arm, subcutaneous) started getting red,tender and warm 24 hrs. after vaccination.  Mom states area is larger today, but less red. 35 mm circular area measured today.
Per mother's report: Had vaccines yesterday.  Today she has a fever of 102 and pain throughout body.  Also nauseous, vomited once.  Says this happened last time with vaccine, so mom believes it is vaccine related.  No other symptoms.
had boil like eruptions on my skin on my second and 3rd shot. they pretty much go away after a month or so but depending on where it happens equals the amount of discomfort
Headache, lightheadedness, syncopal episode.  Taken by ambulance to hospital.  Took about an hour to return to normal state of consciousness.  Received Toradol and Zofran for headache.
Contracted COVID-19 infection after vaccination; This spontaneous case was reported by a patient family member or friend and describes the occurrence of COVID-19 (Contracted COVID-19 infection after vaccination) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Contracted COVID-19 infection after vaccination). At the time of the report, COVID-19 (Contracted COVID-19 infection after vaccination) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       Concomitant medications were not provided by the reporter. Patient experienced COVID-19. Reporter wanted to know, howlong could patient give it to someone else. Because they want to go visit. Reporter guessed they were vaccinated. She never mentioned they were vaccinated with the Moderna COVID-19 vaccine. Treatment information was not provided. Company comment: This spontaneous case concerns a female patient of unknown age with no reported medical history, who experienced the unexpected, non-serious AESI of COVID-19. The exact date of administration of an unknown dose of mRNA-1273 and onset of the event was not specified, hence latency could not be assessed. Details of concomitant medications, medical history, clinical course and treatment were not provided. The outcome of the event was unknown at the time of the report. The benefit-risk relationship of mRNA-1273 is not affected by this report.   Reporter did not allow further contact; Sender's Comments: This spontaneous case concerns a female patient of unknown age with no reported medical history, who experienced the unexpected, non-serious AESI of COVID-19. The exact date of administration of an unknown dose of mRNA-1273 and onset of the event was not specified, hence latency could not be assessed. Details of concomitant medications, medical history, clinical course and treatment were not provided. The outcome of the event was unknown at the time of the report. The benefit-risk relationship of mRNA-1273 is not affected by this report.
FEELING CLAMMY; FEELING WARM; HYPERVENTILATION; FATIGUE; This spontaneous report received from a patient concerned a 59 year old female. The patient's weight was 160 pounds, and height was 160 centimeters. The patient's past medical history included blood clot on both lungs, and blood clot on legs, and concurrent conditions included alcohol user, cigarette smoker, seasonal allergy, penicillin allergy, and sulfa drugs allergy, and other pre-existing medical conditions included patient had no drug abuse and drug illicit usage.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, and batch number: 203A21A expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. Concomitant medications included acetylsalicylic acid for prevention of blood clot.  On 08-APR-2021, the subject experienced feeling clammy. On 08-APR-2021, the subject experienced feeling warm. On 08-APR-2021, the subject experienced hyperventilation. On 08-APR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from hyperventilation on 08-APR-2021, and had not recovered from feeling clammy, feeling warm, and fatigue. This report was non-serious.
Wheezing, nausea, congestion, joint pain, neck stiffness, severe sinus congestion.
inflammation; warm; redness; This is a spontaneous report from a contactable pharmacist via a Pfizer sales representative. This pharmacist reported same events for 2 patients. This is 1st of 2 reports. A patient of unspecified age and gender received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) (PREVNAR 13; lot number X62324), via an unspecified route of administration on an unspecified date at a single dose for immunization. The patient's medical history and concomitant medications were not reported. The pharmacist reported inflammation, warm and redness in a patient previously vaccinated with pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein). The reporter suspected that these reactions were caused by the same lot number (X62324). Outcome of the events was unknown.; Sender's Comments: Linked Report(s) : PR-PFIZER INC-2019345712 same reporter/drug/event, different patient
Patient received Fluarix quad vaccine on 11/02/14. She called on 12/18 concerned that she still has pain in her arm and wanted to know if its from vaccine. She has not seen a doctor yet.
tested positive for Covid 19; tested positive for Covid 19; This is a spontaneous report from a contactable consumer. This consumer reported similar events for 2 patients (Herself and husband). This is a 1st of 2 reports. This 70-year-old female consumer (patient) reported for herself. A 70-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: not reported) via an unspecified route of administration on 14Jan2021 as single dose for COVID-19 immunization. The patient medical history and concomitant medications was not reported. The caller says that she had her first vaccine shot and was ready to get her second shot but she got the COVID week after first dose in 2021. She says that she had her appointment for on the second, then on the first she tested positive. Caller says something about her husband and daughter two days later, and a week after. Unable to clarify with caller due to poor sound quality and caller speaking over call handler. She says her question was can she get the second dose of the vaccine still and how soon she can get it. She says her husband is 84, and she is 70, and they had very mild symptoms, so she thinks the vaccine helped them, which her daughter had it worse. The patient underwent lab tests and procedures which included sars-cov-2 test: positive. The outcome of the events was unknown  Information about lot/batch has been requested.  Follow-up attempts are completed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021180363 same reporter/vaccine/AE, different patients
Information has been received from a nurse practitioner concerning a 15 year old female who in September 2007, was vaccinated with Gardasil.  In September 2007, "within 15 minutes" after receiving vaccination the patient experienced syncope.  Unspecified medical attention was sought.  Subsequently, the patient recovered from the syncope and was reported as being fine.  No further information is expected.
Feeling tired; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Feeling tired) in a 92-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025302A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Jan-2021, the patient experienced FATIGUE (Feeling tired). At the time of the report, FATIGUE (Feeling tired) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 04-Jun-2021: TCR; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
right left eye appears normal. the skin around the eyes is erythema and edematous more on right than left No frank nasal or ear discharge.
Over first 15 min after vaccine, face started itching. While in the 30  min observation room, realized that hives had started on her face, itching on arms but no hives anywhere other than her face  She reports that she had the same reaction following the first dose. Reported it to the CDC but not to VAERS. Hives developed 1 hour after vaccine following the first dose  Hives started improving
I got my first dose of the Moderna covid vaccine on 01/14/2021 at NY. my arms was hurting me but it was not swollen. when I got the second doses of the vaccine which was on 02/11/2021 on Hospital, I had fever, chill and body ache for two days after two days ( 02/13/2021) my arms started to get swollen, red and my skin around it was very hot. the third day it got worse and was itchy. I wanted to know, what was wrong here? cause none of my friends and family experienced this problem. Can someone get back to me? thank you
This is a spontaneous report from a contactable consumer reporting for her son. A 17-year-old male patient received TRUMENBA, (lot number and expiration date were unknown) via an unspecified route of administration in the arm on 05Jun2018 at a single dose for immunization.  The patient medical history was not reported. There were no concomitant medications. The reporter stated "he received the shot yesterday (on 05Jun2018) and when he received the shot he complaint about not feeling well, last night he went to bed I guess kind of hauntable without of it but he came home today from school he had two tests to take and he said how he was not able to focus and his stomach was burning, like he had a burning sensation in his stomach, he was unable to eat lunch today. The arm in which he received the shot, it's still aching and he is sleeping right now, he is just really been fatigued. It stayed with him all of the day, with this headache he was feeling, he was not able to concentrate and is again not been able to eat for lunch time because his stomach was like burning." All the events occurred on an unspecified date in Jun2018. The reporter stated that the patient was a healthy boy. The outcome of the events was unknown. The information on the batch number has been requested.
Starting 2 days after my second vaccine I started experiencing brain fog and dizziness. Within days I started having heart palpitations and anxiety. Then came extreme fatigue and soon after I started to experience panic attacks. I could not sleep through the night for 2 months. Until I started taking a med the Dr prescribed. I also started spotting.
Break Through COVID on Aug 16th 2022. Lasting 4 days, treated with Paxlovid, Rebound infection on Aug 23 lasting until Sep 2.
Rcvd Tdap, Varicella, MCV4 and HPV.  After receiving the last dose (was HPV) - started to seize - lasted approximately 30 seconds of jerking and then went limp.  Came to immediately and was alert and oriented.
Received a third shot due to immunosuppression. Began to feel unwell by that evening (headache, feeling hot, fatigue). I woke up the next morning with a significant flare of my vasculitis, the first one I have had in four months. The rash was very hot and spread more than usual covering my trunk, thighs, arms and chest. Today is day two of this flare. It is still red and hot but not spreading any further. My rheumatologist prescribed 10mg of prednisone if needed, but trying to not take to allow immune response.
pain in the arm/arm hurt; red mark in the shoulder; red mark in the shoulder which hurt; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (red mark in the shoulder), PAIN (red mark in the shoulder which hurt) and PAIN IN EXTREMITY (pain in the arm/arm hurt) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Blood transfusion (after almost bleeding to death). Concurrent medical conditions included Stomach cancer (Five years ago, patient had stomach cancer.), Blood disorder (patient caught a rare blood disease in which white blood cells attack red blood cells.Patient takes medication to treat conditions.) and Immunocompromised.   On 02-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced ERYTHEMA (red mark in the shoulder) and PAIN (red mark in the shoulder which hurt). On an unknown date, the patient experienced PAIN IN EXTREMITY (pain in the arm/arm hurt). At the time of the report, ERYTHEMA (red mark in the shoulder), PAIN (red mark in the shoulder which hurt) and PAIN IN EXTREMITY (pain in the arm/arm hurt) outcome was unknown.            Patient qualified as immunocompromised, so received 3rd dose.   No treatment information was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Joint Pain (Joint pain), Generalized fatigue (fatigue) High laboratory levels Anti-CCP (high anti ccp levels) No treatment has been provided. Awaiting for an appointment with a rheumatologist.
Rec'd DTap and Ipol in left arm in 3/27/2006 woke 3/28/2006 with some redness. Worsen by 3/29/2006 came in for office visit DX with left are cellulitis immunizations.